MNTAUnknown

MOMENTA PHARMACEUTICALS INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for MOMENTA PHARMACEUTICALS INC (MNTA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Are MNTA insiders buying or selling?

MOMENTA PHARMACEUTICALS INC insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 279 Form 4 filings for MNTA: 0 buys ($0) and 279 sells ($57.5M).

Source: SEC EDGAR Form 4

Key Statistics (January 2018 – Aug 21, 2020)

Total Form 4 filings
279
SEC EDGAR
Insider filers
17
Insider buys (0)
$0
Insider sells (279)
$57.5M

Insider sentiment

Net selling

Net insider flow of $57.5M in net selling since January 2018.

Recent MNTA insider transactions

DateInsiderRoleTypeSharesPriceValueFiling
Aug 21, 2020Ian FierChief Mfg and Program OfficerSale1.8K$52.17$94.3KSEC ↗
Aug 20, 2020Jose-Carlos Gutierrez-RamosDirectorSale10.0K$52.09$520.9KSEC ↗
Aug 13, 2020Anthony M. ManningChief Scientific OfficerSale403$29.31$11.8KSEC ↗
Aug 13, 2020Craig A WheelerPresident & CEOSale2.8K$28.55$79.3KSEC ↗
Aug 13, 2020JO Ann BeltramelloChief HR and Inf. OfficerSale6.9K$28.02$194.0KSEC ↗
Aug 11, 2020Anthony M. ManningChief Scientific OfficerSale347$32.36$11.2KSEC ↗
Aug 11, 2020Young KwonChief Financial & Bus. OfficerSale652$32.36$21.1KSEC ↗
Aug 11, 2020Ian FierChief Mfg and Program OfficerSale330$32.36$10.7KSEC ↗
Aug 11, 2020JO Ann BeltramelloChief HR and Inf. OfficerSale3.3K$32.07$106.2KSEC ↗
Aug 11, 2020Craig A WheelerPresident & CEOSale2.6K$31.21$81.2KSEC ↗
Aug 7, 2020Steven C GilmanDirectorSale13.0K$32.75$425.8KSEC ↗
Aug 7, 2020Georges GemayelDirectorSale10.0K$33.00$330.0KSEC ↗
Aug 6, 2020Santiago ArroyoSVP, Chief Medical OfficerSale34.6K$32.25$1.1MSEC ↗
Aug 6, 2020Ian FierChief Mfg and Program OfficerSale25.0K$32.76$818.0KSEC ↗
Jul 30, 2020Santiago ArroyoSVP, Chief Medical OfficerSale39.6K$30.00$1.2MSEC ↗
Jul 30, 2020Georges GemayelDirectorSale10.0K$30.00$300.0KSEC ↗
Jul 30, 2020Steven C GilmanDirectorSale10.0K$29.70$297.0KSEC ↗
Jul 28, 2020Santiago ArroyoSVP, Chief Medical OfficerSale681$30.00$20.4KSEC ↗
Jul 28, 2020JO Ann BeltramelloChief HR and Inf. OfficerSale1.2K$30.00$36.6KSEC ↗
Jul 23, 2020Steven C GilmanDirectorSale10.0K$33.23$332.3KSEC ↗
Jul 23, 2020Ian FierChief Mfg and Program OfficerSale33.5K$32.48$1.1MSEC ↗
Jul 23, 2020Anthony M. ManningChief Scientific OfficerSale1.9K$34.69$67.3KSEC ↗
Jul 23, 2020Santiago ArroyoSVP, Chief Medical OfficerSale51.9K$34.53$1.8MSEC ↗
Jul 21, 2020Santiago ArroyoSVP, Chief Medical OfficerSale1.6K$33.95$53.0KSEC ↗
Jul 21, 2020Anthony M. ManningChief Scientific OfficerSale51.1K$33.91$1.7MSEC ↗

Showing the 25 most recent of 279 Form 4 filings for MOMENTA PHARMACEUTICALS INC.

Most active MNTA insiders

  • Craig A Wheeler44 filings
  • JO Ann Beltramello43 filings
  • Ian Fier40 filings
  • Young Kwon39 filings
  • Anthony M. Manning36 filings

Ask anything about MNTA insider activity

Use Trabud's AI agent to query MOMENTA PHARMACEUTICALS INC's Form 4 history in plain English — "Show me MNTA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

MNTA insider trading FAQ

Are MOMENTA PHARMACEUTICALS INC insiders buying or selling?

MOMENTA PHARMACEUTICALS INC insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 279 Form 4 filings for MNTA: 0 buys ($0) and 279 sells ($57.5M). Over the full record that is net selling of $57.5M.

How many insiders trade MNTA stock?

17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for MOMENTA PHARMACEUTICALS INC. The most recent filing was accepted on Aug 21, 2020.

Where does Trabud get MNTA insider trading data?

All MNTA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Related Content